Rhabdomyosarcoma

SX Skapek, A Ferrari, AA Gupta, PJ Lupo… - Nature reviews disease …, 2019 - nature.com
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and
represents a high-grade neoplasm of skeletal myoblast-like cells. Decades of clinical and …

Fibroblast growth factor receptors as treatment targets in clinical oncology

M Katoh - Nature reviews Clinical oncology, 2019 - nature.com
FGFRs are receptor tyrosine kinases with a role in several biological processes, such as the
regulation of development and tissue repair. However, alterations in FGFRs 1–4, such as …

The role of STAT3 in leading the crosstalk between human cancers and the immune system

Y Wang, Y Shen, S Wang, Q Shen, X Zhou - Cancer letters, 2018 - Elsevier
The development and progression of human cancers are continuously and dynamically
regulated by intrinsic and extrinsic factors. As a converging point of multiple oncogenic …

Targeting FGFR signaling in cancer

M Touat, E Ileana, S Postel-Vinay, F André… - Clinical cancer …, 2015 - AACR
The fibroblast growth factor signaling pathway (FGFR signaling) is an evolutionary
conserved signaling cascade that regulates several basic biologic processes, including …

Strategies and approaches of targeting STAT3 for cancer treatment

SL Furtek, DS Backos, CJ Matheson… - ACS chemical …, 2016 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates the expression of genes related to cell cycle, cell survival, and immune response …

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

YK Chae, K Ranganath, PS Hammerman… - …, 2016 - pmc.ncbi.nlm.nih.gov
The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) is a tyrosine kinase
signaling pathway that has a fundamental role in many biologic processes including …

Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours

DTW Jones, A Banito, TGP Grünewald, M Haber… - Nature Reviews …, 2019 - nature.com
The spectrum of tumours arising in childhood is fundamentally different from that seen in
adults, and they are known to be divergent from adult malignancies in terms of cellular …

Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies

FH Tan, TL Putoczki, SS Stylli… - OncoTargets and therapy, 2019 - Taylor & Francis
Human malignancies are often the result of overexpressed and constitutively active receptor
and non-receptor tyrosine kinases, which ultimately lead to the mediation of key tumor …

Current and future treatment strategies for rhabdomyosarcoma

C Chen, H Dorado Garcia, M Scheer… - Frontiers in …, 2019 - frontiersin.org
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, and can be
subcategorized histologically and/or based on PAX-FOXO1 fusion gene status. Over the last …

[HTML][HTML] Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis

Q Chen, J Lv, W Yang, B Xu, Z Wang, Z Yu, J Wu… - Theranostics, 2019 - ncbi.nlm.nih.gov
Atherosclerosis is the main pathological basis of ischemic cardiovascular and
cerebrovascular diseases and has attracted more attention in recent years. Multiple studies …